Investigating the anti-inflammatory effect of dexamethasone in an asthma mouse model

dc.contributor.authorKirkil, Gamze
dc.contributor.authorMuz, M Hamdi
dc.contributor.authorDeveci, Figen
dc.contributor.authorBulut, Hakan
dc.contributor.authorEröksüz, Yesari
dc.contributor.authorIlhan, Necip
dc.contributor.authorTurgut, Teyfik
dc.date.accessioned2026-08-12T16:10:49Z
dc.date.issued2005
dc.departmentFırat Üniversitesi
dc.description.abstractWe performed an asthma mice model in this study and aimed to investigate the levels of mediators in bronchoalveolar lavage fluid (BALF), and lung tissue, and the pathological changes response to the steroid treatment. BALB/c mice divided into three groups. PBS was applied to group 1 (control group). Asthma model was performed by exposing to ovalbumin in group 2 and 3. DEX was injected to group 3. After the last DEX dose all of the mice were killed by cervical dislocation. The samples of BALF and lung tissue were obtained. IL-4 and IL-5 levels of all samples were measured and inflammatory cells were counted in BALF. Evident eosinophilia was determined in BALF of group 2. Eosinophil numbers were lower in group 3 when compared with group 2 and this was statistically significant (p< 0.001). Inflammatory cell infiltration, eodema and hyperemia observed around the walls of bronchus and bronchiols in group 2. The lungs of group 3 had normal histological appearance. Both two cytokin levels of lung tissue were higher in group 2 than group 1, and this was statistically significant (for IL-4 p< 0.003, and for IL-5 p< 0.002). In group 3, both two cytokin levels were statistically lower than group 2 (for IL-4 p< 0.001, and for IL-5 p< 0.026). In BALF samples both two cytokin levels were higher in group 2 than group 1, and this was statistically significant (for IL-4 p< 0.004, and for IL-5 p< 0.001). In group 3, both two cytokin levels were lower than group 2, but it was not statistically significant (p> 0.05). In conclusion, it is thought that antiinflammatory effect of glucocorticoids occur by inhibiting the formation of IL-4, IL-5 and eosinophils.
dc.identifier.endpage251
dc.identifier.issn0494-1373
dc.identifier.issue3
dc.identifier.pmid16258883
dc.identifier.scopus2-s2.0-33644875980
dc.identifier.scopusqualityQ3
dc.identifier.startpage245
dc.identifier.urihttps://hdl.handle.net/11508/42142
dc.identifier.volume53
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isotr
dc.relation.ispartofTüberküloz ve toraks
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20260511
dc.subjectAnimals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Dexamethasone; Disease Models, Animal; Female; Immunohistochemistry; Interleukin-4; Interleukin-5; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Random Allocation; antiinflammatory agent; dexamethasone; interleukin 4; interleukin 5; ovalbumin; animal; animal disease; article; asthma; Bagg albino mouse; cytology; disease model; female; immunohistochemistry; immunology; lung; lung lavage; mouse; pathology; randomization
dc.titleInvestigating the anti-inflammatory effect of dexamethasone in an asthma mouse model
dc.title.alternativeAstim fare modelinde deksametazonun antiinflamatuvar etkisinin araştirilmasi.
dc.typeArticle

Dosyalar